5
4.5.3.
α-(N-Boc)amino-N’,N’-dimethyl-(4-dimethylamino)phe-
107.9, 80.0, 49.2, 36.9, 36.9, 28.4; Anal. Calcd for C13H20N2O4:
C, 58.19; H, 7.51; N, 10.44. Found: C, 58.45; H, 7.73; N, 10.21.
ACCEPTED MANUSCRIPT
nylacetamide (3c). Yield=76%; mp=148.5–150.0 ; IR (KBr)
1
ν
max: 3291, 1706, 1654, 1524, 1366, 1248, 1165 cm–1; H NMR
4.5.10. α-(N-Boc)amino-N’,N’-dimethyl-(2)-thienylacetamide (3j).
Yield=73%; mp=73.5–74.5 ; IR (KBr) νmax: 3409, 3314, 1703,
(600MHz, CDCl3) δH: 6.67–7.24 (m, 4H, Ar–H), 5.94 (d, 1H, J =
7.8 Hz, NH), 5.47 (d, 1H, J = 7.8 Hz, CHN), 2.90–2.97 (m, 12H,
(CH3)2NPh, (CH3)2N), 1.41 (s, 9H, (CH3)3C); 13C NMR (151MHz,
CDCl3) δC: 170.6, 155.1, 150.2, 128.6, 125.5, 112.6, 79.3, 54.6,
40.4, 36.9, 35.9, 28.4; Anal. Calcd for C17H27N3O3: C, 63.53; H,
8.47; N, 13.07. Found: C, 63.81; H, 8.69; N, 12.89.
1645, 1523, 1482, 1167 cm–1; H NMR (600MHz, CDCl3) δH:
1
7.26 (d, 1H, J = 4.8 Hz, Thienyl-5-H), 6.94–7.01 (m, 2H,
Thienyl-3-H, Thienyl-4-H), 5.99 (d, 1H, J = 7.8 Hz, NH), 5.83 (d,
1H, J = 7.8 Hz, CHN), 3.01 (s, 3H, CH3N), 2.99 (s, 3H, CH3N),
1.43 (s, 9H, (CH3)3C); 13C NMR (151MHz, CDCl3) δC: 169.3,
154.9, 140.5, 126.8, 126.0, 125.9, 79.9, 50.2, 37.1, 36.0, 28.4;
Anal. Calcd for C13H20N2O3S: C, 54.91; H, 7.09; N, 9.85. Found:
C, 54.68; H, 7.31; N, 9.62.
4.5.4. α-(N-Boc)amino-N’,N’-dimethyl-(4-methoxy)phenylacet-
amide (3d). Yield=77%; mp=138.0–139.5 ; IR (KBr) νmax
:
3302, 1703, 1641, 1510, 1263, 1162 cm–1; H NMR (600MHz,
CDCl3) δH: 6.87–7.32 (m, 4H, Ar–H), 6.01(d, 1H, J = 7.2 Hz,
NH), 5.51 (d, 1H, J = 7.2 Hz, CHN), 3.81 (s, 3H, CH3O), 2.99 (s,
3H, CH3N), 2.09 (s, 3H, CH3N), 1.42 (s, 9H, (CH3)3C); 13C NMR
(151MHz, CDCl3) δC: 170.3, 159.4, 155.1, 130.1, 129.0, 114.3,
79.6, 55.3, 54.6, 36.9, 36.0, 28.4; Anal. Calcd for C16H24N2O4: C,
62.32; H, 7.84; N, 9.08. Found: C, 62.56; H, 7.56; N, 9.29.
1
4.5.11.
α-(N-Boc)amino-N’,N’-dimethyl-(2)-pyridylacetamide
(3k). Yield=82%; yellow liquid; IR (KBr) νmax: 3414, 3387, 1710,
1653, 1485, 1390, 1247, 1164 cm–1; H NMR (600MHz, CDCl3)
1
δH: 8.55 (d, 1H, J = 4.2 Hz, pyridyl-6-H), 7.68-7.71 (m, 1H,
pyridyl-4-H), 7.46 (d, 1H, J = 7.8 Hz, pyridyl-3-H), 7.20–7.22
(m, 1H, pyridyl-5-H), 6.25 (d, 1H, J = 7.2 Hz, NH), 5.80 (d, 1H,
J = 7.2 Hz, CHN), 3.11 (s, 3H, CH3N), 3.01 (s, 3H, CH3N),
1.44 (s, 9H, (CH3)3C); 13C NMR (151MHz, CDCl3) δC: 169.5,
158.0, 155.2, 149.4, 137.1, 122.8, 121.8, 79.8, 56.6, 37.4, 36.1,
28.4; Anal. Calcd for C14H21N3O3: C, 60.20; H, 7.58; N, 15.04.
Found: C, 60.46; H, 7.79; N, 15.33.
4.5.5. α-(N-Boc)amino-N’,N’-dimethyl-(4-methyl)phenylacetam-
ide (3e). Yield=72%; mp=133.0–134.5 ; IR (KBr) νmax: 3296,
1703, 1641, 1523, 1392, 1263, 1162 cm–1; H NMR (600MHz,
1
CDCl3) δH: 7.16–7.28 (m, 4H, Ar–H), 6.20 (d, 1H, J = 7.2 Hz,
NH), 5.30 (d, 1H, J = 7.2 Hz, CHN), 3.00 (s, 3H, CH3N), 2.90 (s,
3H, CH3N), 2.35 (d, 3H, J = 2.4 Hz, CH3), 1.42 (s, 9H, (CH3)3C);
13C NMR (151MHz, CDCl3) δC: 170.2, 155.1, 137.9, 135.0,
130.0, 127.6, 79.6, 54.9, 36.9, 36.0, 28.4, 21.2; Anal. Calcd for
C16H24N2O3: C, 65.73; H, 8.27; N, 9.58. Found: C, 65.90; H,
8.56; N, 9.79.
4.5.12. α-(N-Boc)amino-N’,N’-dimethyl-4-phenyl-2-butenylam-
ide (3l). Yield=78%; yellow liquid; IR (KBr) νmax: 3417, 3387,
1710, 1649, 1489, 1396, 1256, 1168 cm–1; H NMR (600MHz,
1
CDCl3) δH: 7.27–7.40 (m, 5H, Ar–H), 6.65 (d, 1H, J = 16.2 Hz,
Ar-CH=), 6.15 (q, 1H, J = 16.2, 7.2 Hz, =CH-CHN), 5.82 (d,
1H, J = 7.8 Hz, NH), 5.23 (t, 1H, J = 7.8, 7.2 Hz, CHN), 3.11
(s, 3H, CH3N), 3.03 (s, 3H, CH3N), 1.46 (s, 9H, (CH3)3C); 13C
NMR (151MHz, CDCl3) δC: 169.9, 155.0, 136.1, 133.3, 128.6,
128.1, 126.7, 124.5, 79.7, 53.5, 53.0, 37.0, 36.0, 28.4; Anal.
Calcd for C17H24N2O3: C, 67.08; H, 7.95; N, 9.20. Found: C,
67.26; H, 7.74; N, 9.30.
4.5.6. α-(N-Boc)amino-N’,N’-dimethylphenylacetamide (3f).
Yield=74%; mp=121.5–123.0 ; IR (KBr) νmax: 3410, 1706,
1638, 1485, 1397, 1164 cm–1; H NMR (600MHz, CDCl3) δH:
1
7.30–7.40 (m, 5H, Ar–H), 6.05 (d, 1H, J = 7.8 Hz, NH), 5.57 (d,
1H, J = 7.8 Hz, CHN), 2.99 (s, 3H, CH3N), 2.91 (s, 3H, CH3N),
1.42 (s, 9H, (CH3)3C); 13C NMR (151MHz, CDCl3) δC: 170.1,
155.1, 138.0, 129.0, 128.2, 127.9, 127.7, 79.7, 55.2, 36.9, 36.0,
28.4; Anal. Calcd for C15H22N2O3: C, 64.73; H, 7.97; N, 10.06.
Found: C, 64.51; H, 7.74; N, 10.16.
Acknowledgments
This research was supported by Shanxi Province Foundation
for Returness (No. 0713), the Natural Science Foundation of
Shanxi Province (No. 2012011046-9) and Foundation of Shanxi
Normal University (No. WL2015CXCY-YJ-21), China.
4.5.7. α-(N-Boc)amino-N’,N’-dimethyl-(4-chloro)phenylacetam-
ide (3g). Yield=89%; mp=137.5–139.0 ; IR (KBr) νmax: 3287,
1
1695, 1638, 1535, 1396, 1164 cm–1; H NMR (600MHz, CDCl3)
δH: 7.33–7.36 (m, 4H, Ar–H), 6.09 (d, 1H, J = 7.2 Hz, NH), 5.53
(d, 1H, J = 7.2 Hz, CHN), 3.00 (s, 3H, CH3N), 2.91 (s, 3H,
CH3N), 1.42 (s, 9H, (CH3)3C); 13C NMR (151MHz, CDCl3) δC:
169.2, 155.0, 136.6, 134.1, 129.2, 79.9, 54.5, 36.9, 36.0, 28.4;
Anal. Calcd for C15H21ClN2O3: C, 57.60; H, 6.77; N, 8.96.
Found: C, 57.80; H, 6.68; N, 8.73.
References and notes
1. (a) Chatel-Chaix, L.; Germain, M. A.; Gotte, M.; Lamarre, D.
Curr. Opin. Virol. 2012, 2, 588–594; (b) Najera, C.; Sansano, J.
M. Chem. Rev. 2007, 107, 4584–4671; (c) Katritzky, A. R.;
Kirichenko, N.; Rogovoy, B. V.; He, H.-Y. J. Org. Chem. 2003,
68, 9088–9092; (d) Amstrong, R. W.; Combs, A. P.; Tempest, P.
A.; Brown, S. D.; Keating, T. A. ACC. Chem. Rev. 1996, 29, 123–
131.
4.5.8. α-(N-Boc)amino-N’,N’-dimethyl-(4-nitro)phenylacetamide
(3h). Yield=84%; mp=174.5–176.0 ; IR (KBr) νmax: 3291, 1706,
1
1654, 1524, 1366, 1165 cm–1; H NMR (600MHz, CDCl3) δH:
2. (a) Cuny, G.; Bois-Choussy, M.; Zhu, J.-P. J. Am. Chem. Soc.
2014, 126, 14475–14484; (b) Escorihuela, J.; Altava, B.;
Burguete, M. I.; Luis, S. V. Tetrahedron 2013, 69, 511–8558; (c)
Escorihuela, J.; Gonzalez, L.; Altava, B.; Burguete, M. I.; Luis, S.
V. Appl. Catal., A 2013, 462, 23–30; (d) Erb, W.; Neuville, L.;
Zhu, J.-P. J. Org. Chem. 2009, 74, 3109–3113.
3. (a) Ugi, I.; Steinbruckner, C. Angew. Chem. 1960, 72, 267–268;
(b) Domling, A.; Ugi, I. Angew. Chem. Int. Ed. 2000, 39, 3168–
3210; (c) Domling, A. Chem. Rev. 2006, 106, 17–89.
8.23 (d, 2H, J = 7.8 Hz, Ar–H), 7.60 (d, 2H, J = 7.8 Hz, Ar–H),
6.21 (d, 1H, J = 7.2 Hz, NH), 5.65 (d, 1H, J = 7.2 Hz, CHN),
3.02 (s, 3H, CH3N), 2.94 (s, 3H, CH3N), 1.42 (s, 9H, (CH3)3C);
13C NMR (151MHz, CDCl3) δC: 168.8, 154.9, 147.7, 145.1,
128.8, 124.3, 80.2, 54.5, 37.0, 36.1, 28.3; Anal. Calcd for
C15H21N3O5: C, 55.72; H, 6.55; N, 13.00. Found: C, 55.62; H,
6.32; N, 13.21.
4. (a) Pick, R.; Bauer, M.; Kazmaier, U.; Hebach, C. Synlett, 2005,
757–760; (b) Basso, A.; Banfi, L.; Riva, R.; Guanti, G. J. Org.
Chem. 2005, 70, 575–579; (c) Rueping, M.; Vila, C. Org. Lett.
2013, 15, 2092–2095; (d) Saha, B.; Frett, B.; Wang, Y.-X.; Li, H.-
Y. Tetrahedron Lett. 2013, 54, 2340–2343.
4.5.9. α-(N-Boc)amino-N’,N’-dimethyl-(2)-furylacetamide (3i).
Yield=76%; mp=89.0–90.5 ; IR (KBr) νmax: 3384, 1706, 1643,
1
1489, 1405, 1169 cm–1; H NMR (600MHz, CDCl3) δH: 7.37, (d,
1H, J = 10.2 Hz, Furyl-5-H), 6.30–6.34 (m, 2H, Furyl-3-H,
5.
Mita, T.; Sugawara, M.; Saito, K.; Sato, Y. Org. Lett. 2014, 16,
3028–3031.
Furyl-4-H), 5.95 (s, 1H, NH), 5.71–5.74 (m, 1H, CHN), 3.02 (s,
3H, CH3N), 3.00 (s, 3H, CH3N), 1.45, 1.44 (ss, 9H, (CH3)3C); 13
C
NMR (151MHz, CDCl3) δC: 168.0, 155.1, 150.6, 142.6, 110.5,